Incidence of Prediabetes and Diabetes in a European Longitudinal General Population Cohort and Its Associated Factors—Results From the Austrian LEAD Study
Authors:
- Amiria Dal GrandeAGAmiria Dal Grande
- Maarten Van HerckMHMaarten Van Herck
- Robab Breyer-KohansalRBRobab Breyer-Kohansal
- Mohammad AzizzadehMAMohammad Azizzadeh
- Sylvia HartlSHSylvia Hartl
- Otto C. BurghuberOBOtto C. Burghuber
- Alexandra Kautzky-WillerAlexandra Kautzky-Willer
- Caspar SchiffersCSCaspar Schiffers
- Marie K. BreyerMBMarie K. Breyer
Open Access
- 1 January 2025
- journal article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1) , 5540276
Abstract
Aims: This study evaluates the incidence of (pre)diabetes in an Austrian population over a broad age span and addresses whether alterations in lifestyle, blood markers, and body composition are associated with the development of (pre)diabetes. Material and Methods: Data from the first and second phases of the Austrian LEAD study, a longitudinal population–based cohort study, were used. Inclusion criteria were a valid glycaemic status (i.e., normoglycaemia, prediabetes, and diabetes) at both phases using American Diabetes Association criteria. Besides blood samples, body composition parameters and an interviewer‐administered questionnaire were assessed. A binary logistic regression was performed to answer the research question. Results: In total, 7822 individuals (51% females, 46 ± 19 years with 9.6% aged < 18 years, median follow‐up time 4.1 [3.9–4.5] years) were included. The overall incidence rate was estimated at 63.0 (95% CI [59.7; 66.3]) and 8.4 (95% CI [7.4; 9.5]) per 1000 person‐years for prediabetes and diabetes, respectively. In the 6–Conclusions: The overall incidence of (pre)diabetes in the Austrian population is high and highlights the need for screening from a young age and on a regular basis so that preventive and treatment strategies can be implemented at an early stage. Trial Registration: ClinicalTrials.gov identifier: NCT01727518Keywords
Funding Information
- GlaxoSmithKline
- Chiesi Farmaceutici
- AstraZeneca
- Ludwig Boltzmann Gesellschaft
This publication has 42 references indexed in Scilit:
- Screening for Prediabetes and Type 2 Diabetes in Children and AdolescentsJAMA, 2022
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studiesDiabetologia, 2021
- Screening for Prediabetes and Type 2 DiabetesJAMA, 2021
- Association of risk factors with type 2 diabetes: A systematic reviewComputational and Structural Biotechnology Journal, 2021
- Development of type 2 diabetes mellitus in people with intermediate hyperglycaemiaCochrane Database of Systematic Reviews, 2018
- Association Between Low-Density Lipoprotein Cholesterol–Lowering Genetic Variants and Risk of Type 2 DiabetesJAMA, 2016
- Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk FactorsJACC, 2016
- Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart StudyDiabetologia, 2015
- Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular BenefitCardiovascular Drugs and Therapy, 2008